Benjamin Daniel Bradford, M.D.
NPI 1629336128ActiveIndividual· Otolaryngology, Facial Plastic Surgery· Stateline, NV
Otolaryngology, Facial Plastic Surgery (M.D.) in Stateline, Nevada, trained at Loma Linda University School of Medicine (class of 2012). 1,089 Medicare patients in 2024, $501,634 paid; nearly all of their 578 Part D prescriptions were generic (94%). Abbvie Inc. was the largest of 6 companies reporting payments in 2025, $737.72 in all, mostly food and beverage.
Overview
| NPI | 1629336128 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | May 3, 2012 |
| Last updated in NPPES | Jan 30, 2023 |
| Certified by provider | Jan 30, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Otolaryngology, Facial Plastic Surgery Primary | 207YS0123X | 22619 | NV |
| Dermatology | 207N00000X | 22619 | NV |
| Otolaryngology, Facial Plastic Surgery | 207YS0123X | A126409 | CA |
| Otolaryngology, Facial Plastic Surgery | 207YS0123X | 286986 | NY |
| Otolaryngology, Plastic Surgery within the Head & Neck | 207YX0007X | 22619 | NV |
| Surgery, Plastic and Reconstructive Surgery | 2086S0122X | 22619 | NV |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Otolaryngology (CA); Practitioner - Otolaryngology (NV) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 1,089 |
|---|---|
| Services billed | 11,291 across 124 procedure codes |
| Paid by Medicare | $501,634 |
Part D prescriptions in 2024
| Prescriptions (claims) | 578 · 630 30-day fills |
|---|---|
| Patients | 280 |
| Total drug cost | $148,776 |
| Generic share | 94% of claims |
Education and affiliations
| Medical school | Loma Linda University School of Medicine |
|---|---|
| Graduation year | 2012 |
| Medicare specialty | Otolaryngology |
| Secondary specialties | Dermatology, Plastic And Reconstructive Surgery |
Medical group
- Martin E. Salm, M.D., Ltd.Stateline, NV · 3 clinicians
Industry payments (Open Payments)
- 2025$737.72 · 29 payments from 6 companies
- 2024$409.88 · 12 payments from 6 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbvie Inc. | $493.67 | 20 |
| Vertex Pharmaceuticals Incorporated | $77.93 | 3 |
| Regeneron Healthcare Solutions, Inc. | $59.56 | 2 |
| Genzyme Corporation | $57.31 | 2 |
| Lilly USA, LLC | $29.72 | 1 |
What the 2025 payments were for
- Food and Beverage$728.07 · 28 payments
- Education$9.65 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records